Lataa...
Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
BACKGROUND: Palivizumab is a humanized monoclonal antibody that prevents severe human respiratory syncytial virus (HRSV) infections. OBJECTIVES: We determined the etiology of respiratory viral infections in palivizumab recipients, and monitored the clinical outcome and HRSV genotype in HRSV-infected...
Tallennettuna:
| Julkaisussa: | J Clin Virol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V.
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7172843/ https://ncbi.nlm.nih.gov/pubmed/18164233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2007.11.012 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|